Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-22 · accession 0001770252-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-23 | 2022-03-22 | MYGN | Lambert Nicole | COO | A - Grant | $0.00 | +33.7K | 251.4K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-22 | A | A | 33,665 | $0.00 | 251,446 | D | — | — |